Global Radiopharmaceuticals Market Key Players Competitive Survey Report 2023

Report ID: ARS2959 | Category: Healthcare | Pages: 96 | Format: PDF | Published Date: September 07,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3650.00 Multi User-$6200.00

Report Description
View Table of Contents

Report Summary

The global Radiopharmaceuticals market size in 2022 is 5200.0 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 9.40% expected in 2023-2029.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Radiopharmaceuticals market include Cardinal Health (U.S.), GE Healthcare (U.S.), Lantheus Medical Imaging (U.S.), Bayer AG (Germany), and Bracco Imaging (Italy). The share of the top 3 players in the Radiopharmaceuticals market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Radiopharmaceuticals market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Diagnostic Procedures accounted for XX% of Radiopharmaceuticals market in 2022. Therapeutic Procedures share of XX%.
Nuclear Reactors accounted for XX% of the Radiopharmaceuticals market in 2022. Cyclotrons accounts for XX%.

Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

COVID-19 Impact:
Outbreak of COVID-19 pandemic due to lockdown restrictions imposed by governments around the world has affected the growth of the global Radiopharmaceuticals market in 2020. The containment measures taken by the governments of various countries in response to control the outbreak of COVID-19 disrupted the entire supply chain by creating logistical interruptions, transportation restrictions, and product supply across borders.

The report analyzes the key trends in each segment of the global Radiopharmaceuticals market along with global and country-level forecasts from 2023 to 2028. Our report segments the market based on types and applications, thereby providing a detailed analysis of the market to help gain an in-depth understanding of the market and enable market participants, stakeholders, investors, etc. to have a clearer understanding of the market and judgment.

Key benefits to stakeholders:
The report provides a comprehensive quantitative analysis of various segments, historical and current market trends, market forecasts, and dynamics of the Radiopharmaceuticals market for 2017-2028.
The research report provides the latest information on the market drivers, challenges and opportunities of the global Radiopharmaceuticals market.
The study profiles the leading as well as the fastest growing regional markets. It further enables stakeholders to identify key country-level markets within each region.
Porter's Five Forces Analysis helps stakeholders assess the impact of new entrants, competitors, supplier strength, buyer strength, and threat of substitution. It helps stakeholders analyze the level of competition in the Radiopharmaceuticals industry and its attractiveness.
The competitive landscape enables stakeholders to understand their competitive environment and gain insight into the current position of the key players in the market.

The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.

Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.

Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.

Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.

Highlights-Regions

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Egypt
South Africa
UAE
Turkey
Saudi Arabia

Player list
Cardinal Health (U.S.)
GE Healthcare (U.S.)
Lantheus Medical Imaging (U.S.)
Bayer AG (Germany)
Bracco Imaging (Italy)
Nordion (Canada)
Advanced Accelerator Applications (France)
NTP Radioisotopes (South Africa)
NorthStar Medical Radioisotopes (U.S.)
Eckert & Ziegler (Germany)
Braun Melsungen AG (Germany)
Smith+Nephew (Germany)

Types list
Diagnostic Procedures
Therapeutic Procedures
Source

Application list
Nuclear Reactors
Cyclotrons

Table of Content

1 Radiopharmaceuticals  Market Introduction and Overview
1.1 Radiopharmaceuticals  Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Inflation Analysis
1.6 The Impact of the Russian-Ukrainian War on the Market
1.7 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Radiopharmaceuticals  Historical Market Analysis by Type
2.1 Market Size Analysis by Types
2.2 Global Radiopharmaceuticals  Revenue and Market Share by Type
2.3 Global Radiopharmaceuticals  Sales and Market Share by Type
3 Global Radiopharmaceuticals  Historical Market Analysis by Application
3.1 Market Size Analysis by Application
3.2 Global Radiopharmaceuticals  Revenue Market Share by Application (2018-2023)
3.3 Global Radiopharmaceuticals  Sales Market Share by Application (2018-2023)
4 Global Market Growth Trends Analysis
4.1 Global Radiopharmaceuticals  Market Size (2018-2023)
4.2 Radiopharmaceuticals  Growth Trends Analysis by Regions
4.2.1 Radiopharmaceuticals  Market Size by Regions: 2018 VS 2023 VS 2029
4.2.2 Radiopharmaceuticals  Historic Revenue Market Size by Regions (2018-2023)
4.2.3 Radiopharmaceuticals  Historic Sales Market Size by Regions (2018-2023)
4.2.4 North America Radiopharmaceuticals  Market Size (2018-2023)
4.2.5 Europe Radiopharmaceuticals  Market Size (2018-2023)
4.2.6 Asia-Pacific Radiopharmaceuticals  Market Size (2018-2023)
4.2.7 Latin America Radiopharmaceuticals  Market Size (2018-2023)
4.2.8 Middle East & Africa Radiopharmaceuticals  Market Size (2018-2023)
5 North America
5.1 North America Radiopharmaceuticals  Revenue by Countries
5.1.1 North America Radiopharmaceuticals  Revenue by Countries (2018-2023)
5.1.2 North America Radiopharmaceuticals  Sales by Countries (2018-2023)
5.2 North America Radiopharmaceuticals  Sales by Types
5.3 North America Radiopharmaceuticals  Sales by Applications
5.4 United States
5.5 Canada
6 Asia Pacific
6.1 Asia Pacific Radiopharmaceuticals  Revenue by Countries
6.1.1 Asia Pacific Radiopharmaceuticals  Revenue by Countries (2018-2023)
6.1.2 Asia Pacific Radiopharmaceuticals  Sales by Countries (2018-2023)
6.2 Asia Pacific Radiopharmaceuticals  Sales by Types
6.3 Asia Pacific Radiopharmaceuticals  Sales by Applications
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Radiopharmaceuticals  Revenue by Countries
7.1.1 Europe Radiopharmaceuticals  Revenue by Countries (2018-2023)
7.1.2 Europe Radiopharmaceuticals  Sales by Countries (2018-2023)
7.2 Europe Radiopharmaceuticals  Sales by Types
7.3 Europe Radiopharmaceuticals  Sales by Applications
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Nordic
8 Latin America
8.1 Latin America Radiopharmaceuticals  Revenue by Countries
8.1.1 Latin America Radiopharmaceuticals  Revenue by Countries (2018-2023)
8.1.2 Latin America Radiopharmaceuticals  Sales by Countries (2018-2023)
8.2 Latin America Radiopharmaceuticals  Sales by Types
8.3 Latin America Radiopharmaceuticals  Sales by Applications
8.4 Brazil
8.5 Argentina
8.6 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Radiopharmaceuticals  Revenue by Countries
9.1.1 Middle East & Africa Radiopharmaceuticals  Revenue by Countries (2018-2023)
9.1.2 Middle East & Africa Radiopharmaceuticals  Sales by Countries (2018-2023)
9.2 Middle East & Africa Radiopharmaceuticals  Sales by Types
9.3 Middle East & Africa Radiopharmaceuticals  Sales by Applications
9.4 Egypt
9.5 South Africa
9.6 UAE
9.7 Turkey
9.8 Saudi Arabia
10 Global Radiopharmaceuticals  Market Competition, by Players
10.1 Global Radiopharmaceuticals  Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Radiopharmaceuticals  Players Market Share in 2022
10.2.2 Top 6 Radiopharmaceuticals  Players Market Share in 2022
10.2.3 Market Competition Trend
10.3 Radiopharmaceuticals  Players Head Office, Business Provided
10.4 Radiopharmaceuticals  Mergers & Acquisitions
10.5 Radiopharmaceuticals  New Entrants and Expansion Plans
11 Players Profiles
11.1 Cardinal Health (U.S.)
11.1.1 Cardinal Health (U.S.) Company Profile
11.1.2 Radiopharmaceuticals  Product Overview
11.1.3 Cardinal Health (U.S.) Radiopharmaceuticals  Market Performance (2018-2023)
11.1.4 Cardinal Health (U.S.) Business Overview
11.1.5 Recent Developments and Plans
11.2 GE Healthcare (U.S.)
11.2.1 GE Healthcare (U.S.) Company Profile
11.2.2 Radiopharmaceuticals  Product Overview
11.2.3 GE Healthcare (U.S.) Radiopharmaceuticals  Market Performance (2018-2023)
11.2.4 GE Healthcare (U.S.) Business Overview
11.2.5 Recent Developments and Plans
11.3 Lantheus Medical Imaging (U.S.)
11.3.1 Lantheus Medical Imaging (U.S.) Company Profile
11.3.2 Radiopharmaceuticals  Product Overview
11.3.3 Lantheus Medical Imaging (U.S.) Radiopharmaceuticals  Market Performance (2018-2023)
11.3.4 Lantheus Medical Imaging (U.S.) Business Overview
11.3.5 Recent Developments and Plans
11.4 Bayer AG (Germany)
11.4.1 Bayer AG (Germany) Company Profile
11.4.2 Radiopharmaceuticals  Product Overview
11.4.3 Bayer AG (Germany) Radiopharmaceuticals  Market Performance (2018-2023)
11.4.4 Bayer AG (Germany) Business Overview
11.4.5 Recent Developments and Plans
11.5 Bracco Imaging (Italy)
11.5.1 Bracco Imaging (Italy) Company Profile
11.5.2 Radiopharmaceuticals  Product Overview
11.5.3 Bracco Imaging (Italy) Radiopharmaceuticals  Market Performance (2018-2023)
11.5.4 Bracco Imaging (Italy) Business Overview
11.5.5 Recent Developments and Plans
11.6 Nordion (Canada)
11.6.1 Nordion (Canada) Company Profile
11.6.2 Radiopharmaceuticals  Product Overview
11.6.3 Nordion (Canada) Radiopharmaceuticals  Market Performance (2018-2023)
11.6.4 Nordion (Canada) Business Overview
11.6.5 Recent Developments and Plans
11.7 Advanced Accelerator Applications (France)
11.7.1 Advanced Accelerator Applications (France) Company Profile
11.7.2 Radiopharmaceuticals  Product Overview
11.7.3 Advanced Accelerator Applications (France) Radiopharmaceuticals  Market Performance (2018-2023)
11.7.4 Advanced Accelerator Applications (France) Business Overview
11.7.5 Recent Developments and Plans
11.8 NTP Radioisotopes (South Africa)
11.8.1 NTP Radioisotopes (South Africa) Company Profile
11.8.2 Radiopharmaceuticals  Product Overview
11.8.3 NTP Radioisotopes (South Africa) Radiopharmaceuticals  Market Performance (2018-2023)
11.8.4 NTP Radioisotopes (South Africa) Business Overview
11.8.5 Recent Developments and Plans
11.9 NorthStar Medical Radioisotopes (U.S.)
11.9.1 NorthStar Medical Radioisotopes (U.S.) Company Profile
11.9.2 Radiopharmaceuticals  Product Overview
11.9.3 NorthStar Medical Radioisotopes (U.S.) Radiopharmaceuticals  Market Performance (2018-2023)
11.9.4 NorthStar Medical Radioisotopes (U.S.) Business Overview
11.9.5 Recent Developments and Plans
11.10 Eckert & Ziegler (Germany)
11.10.1 Eckert & Ziegler (Germany) Company Profile
11.10.2 Radiopharmaceuticals  Product Overview
11.10.3 Eckert & Ziegler (Germany) Radiopharmaceuticals  Market Performance (2018-2023)
11.10.4 Eckert & Ziegler (Germany) Business Overview
11.10.5 Recent Developments and Plans
11.11 Braun Melsungen AG (Germany)
11.11.1 Braun Melsungen AG (Germany) Company Profile
11.11.2 Radiopharmaceuticals  Product Overview
11.11.3 Braun Melsungen AG (Germany) Radiopharmaceuticals  Market Performance (2018-2023)
11.11.4 Braun Melsungen AG (Germany) Business Overview
11.11.5 Recent Developments and Plans
11.12 Smith+Nephew (Germany)
11.12.1 Smith+Nephew (Germany) Company Profile
11.12.2 Radiopharmaceuticals  Product Overview
11.12.3 Smith+Nephew (Germany) Radiopharmaceuticals  Market Performance (2018-2023)
11.12.4 Smith+Nephew (Germany) Business Overview
11.12.5 Recent Developments and Plans
12 Global Radiopharmaceuticals  Forecast Market Analysis by Type
12.1 Global Radiopharmaceuticals  Revenue Market Forecast by Type (2023-2029)
12.2 Global Radiopharmaceuticals  Sales Market Forecast by Type (2023-2029)
13 Global Radiopharmaceuticals  Forecast Market Analysis by Application
13.1 Radiopharmaceuticals  Revenue Market Forecast by Application (2023-2029)
13.2 Radiopharmaceuticals  Sales Market Forecast by Application (2023-2029)
14 Global Market Growth Forecast Analysis
14.1 Global Radiopharmaceuticals  Forecast Market Size (2023-2029)
14.2 Radiopharmaceuticals  Growth Trends Forecast Analysis by Regions
14.2.1 Radiopharmaceuticals  Revenue Forecast Market Size by Regions (2023-2029)
14.2.2 Radiopharmaceuticals  Sales Forecast Market Size by Regions (2023-2029)
14.2.3 North America Radiopharmaceuticals  Forecast Market Size (2023-2029)
14.2.4 Europe Radiopharmaceuticals  Forecast Market Size (2023-2029)
14.2.5 Asia-Pacific Radiopharmaceuticals  Forecast Market Size (2023-2029)
14.2.6 Latin America Radiopharmaceuticals  Forecast Market Size (2023-2029)
14.2.7 Middle East & Africa Radiopharmaceuticals  Forecast Market Size (2023-2029)
15 Radiopharmaceuticals  Manufacturing Cost Analysis
15.1 Radiopharmaceuticals  Key Raw Materials Analysis
15.1.1 Key Raw Materials
15.1.2 Price Trend of Key Raw Materials
15.1.3 Key Suppliers of Raw Materials
15.2 Proportion of Manufacturing Cost Structure
15.2.1 Raw Materials
15.2.2 Labor Cost
15.2.3 Manufacturing Expenses
15.3 Manufacturing Process Analysis of Radiopharmaceuticals 
15.4 Radiopharmaceuticals  Industrial Chain Analysis
16 Market Channel, Distributors, Traders and Dealers
16.1 Market Channel Status
16.1.1 Direct Marketing
16.1.2 Indirect Marketing
16.2 Radiopharmaceuticals  Typical Distributors
16.3 Radiopharmaceuticals  Typical Customers
17 Radiopharmaceuticals  Industry Dynamic Analysis
17.1 Radiopharmaceuticals  Market Trends Analysis
17.2 Radiopharmaceuticals  Market Drivers Analysis
17.3 Radiopharmaceuticals  Market Challenges Analysis
17.4 Radiopharmaceuticals  Market Restraints Analysis
18 Research Findings and Conclusion

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Radiopharmaceuticals Market Key Players Competitive Survey Report 2023

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?